← All organizations
First clinical trial
Dec 1, 2006Last known activity
Jun 30, 2020
Acquired by ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. → NantWorks → ImmunityBio, Inc. on Dec 21, 2020
Timeline
2000s
- Jun 1, 2002
NantWorks— Founded
2010s
- Oct 19, 2015
Precision Biologics, Inc— Acquired
2020s
- Dec 21, 2020
ImmunityBio, Inc.— Acquired By
- Dec 21, 2020
ImmunityBio, Inc.— Now
- Dec 21, 2020
ImmunityBio, Inc.— Acquired
Drugs by trial phase (83 distinct, 106 trials)
Phase 3 (0 own, 9 via acquisition)
Phase 2 (0 own, 54 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Chordoma
- Colorectal Neoplasms
- Glioblastoma
- Infections
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Neoplasm Metastasis
- Neoplasms
- Neuroblastoma
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Sarcoma
- Sarcoma, Clear Cell
- Squamous Cell Carcinoma of Head and Neck
- Triple Negative Breast Neoplasms
Subsidiaries (2 direct, 62 total across the full acquisition tree)
- ImmunityBio, Inc.
- Precision Biologics, Inc
- NantCell, Inc. L2
- NantWorks L2
- Altor Bioscience L3
- ImmunityBio, Inc. L3
- Precision Biologics, Inc L3
- NantCell, Inc. L4
- NantWorks L4
- Altor Bioscience L5
- ImmunityBio, Inc. L5
- Precision Biologics, Inc L5
- NantCell, Inc. L6
- NantWorks L6
- Altor Bioscience L7
- ImmunityBio, Inc. L7
- Precision Biologics, Inc L7
- NantCell, Inc. L8
- NantWorks L8
- Altor Bioscience L9
- ImmunityBio, Inc. L9
- Precision Biologics, Inc L9
- NantCell, Inc. L10
- NantWorks L10
- Altor Bioscience L11
- ImmunityBio, Inc. L11
- Precision Biologics, Inc L11
- NantCell, Inc. L12
- NantWorks L12
- Altor Bioscience L13
- ImmunityBio, Inc. L13
- Precision Biologics, Inc L13
- NantCell, Inc. L14
- NantWorks L14
- Altor Bioscience L15
- ImmunityBio, Inc. L15
- Precision Biologics, Inc L15
- NantCell, Inc. L16
- NantWorks L16
- Altor Bioscience L17
- ImmunityBio, Inc. L17
- Precision Biologics, Inc L17
- NantCell, Inc. L18
- NantWorks L18
- Altor Bioscience L19
- ImmunityBio, Inc. L19
- Precision Biologics, Inc L19
- NantCell, Inc. L20
- NantWorks L20
- Altor Bioscience L21
- ImmunityBio, Inc. L21
- Precision Biologics, Inc L21
- NantCell, Inc. L22
- NantWorks L22
- Altor Bioscience L23
- ImmunityBio, Inc. L23
- Precision Biologics, Inc L23
- NantCell, Inc. L24
- NantWorks L24
- Altor Bioscience L25
- ImmunityBio, Inc. L25
- Precision Biologics, Inc L25
Recent trials (29)
- NCT04397796Lead sponsorPhase 1Jun 30, 2020
- NCT04052061Lead sponsorPhase 1Sep 16, 2019
- NCT04050709Lead sponsorPhase 1Jul 18, 2019
- NCT03853317Study chairPhase 2Mar 31, 2019
- NCT03853317Lead sponsorPhase 2Mar 31, 2019
- NCT03554109Lead sponsorPhase 2Sep 30, 2018
- NCT03574649Lead sponsorPhase 2Sep 30, 2018
- NCT03647423Lead sponsorPhase 1/Phase 2Aug 31, 2018
- NCT03563144Lead sponsorPhase 2Aug 31, 2018
- NCT03552718Lead sponsorPhase 1Aug 10, 2018
- NCT03586869Lead sponsorPhase 1/Phase 2Jul 28, 2018
- NCT03563170Lead sponsorPhase 1/Phase 2May 25, 2018
- NCT03563157Lead sponsorPhase 1/Phase 2May 25, 2018
- NCT03387085Lead sponsorPhase 1/Phase 2Mar 16, 2018
- NCT03387111Lead sponsorPhase 1/Phase 2Jan 13, 2018
Details
- Founded
- San Diego, CA, US Jun 1, 2002
- Last known activity
- Jun 30, 2020
Notes
--- Pre-folding founded info: 2009-06-01 Culver City CA United States https://www.nantpharma.com/contact-us ---